Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.81 |
| ▸ | RAB9A | P51151 | 5/20 | 0.81 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.81 |
| ▸ | NPC1 | O15118 | 4/20 | 0.81 |
| ▸ | MEN1 | O00255 | 3/20 | 0.81 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.79 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.79 |
| ▸ | PKM | P14618 | 1/20 | 0.79 |
| ▸ | CRHBP | P24387 | 1/20 | 0.79 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.79 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.79 |
| ▸ | MIF | P14174 | 2/20 | 0.77 |
| ▸ | GPR55 | Q9Y2T6 | 4/20 | 0.70 |
| ▸ | THRB | P10828 | 1/20 | 0.68 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.68 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | HTT | P42858 | 1/20 | 0.63 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.62 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14127097 | 0.91 | EPHX1 (0.78) | ALDH1A1RAB9AKMT2ANPC1MEN1 | |
| SCHEMBL3050895 | 0.88 | ALDH1A1 (0.70) | ALDH1A1RAB9AKMT2ANPC1MEN1 | |
| SCHEMBL28024180 | 0.87 | MIF (1.00) | ALDH1A1RAB9AKMT2ANPC1MEN1 | |
| SCHEMBL3039438 | 0.86 | ALDH1A1 (0.76) | ALDH1A1RAB9AKMT2ANPC1MEN1 | |
| SCHEMBL3059579 | 0.86 | EPHX1 (0.83) | ALDH1A1RAB9AKMT2ANPC1MEN1 | |
| SCHEMBL3055480 | 0.86 | ALDH1A1 (0.81) | ALDH1A1RAB9AKMT2ANPC1MEN1 | |
| SCHEMBL3056870 | 0.85 | KMT2A (0.66) | ALDH1A1RAB9AKMT2ANPC1MEN1 | |
| SCHEMBL5458088 | 0.82 | KMT2A (0.70) | ALDH1A1RAB9AKMT2ANPC1MEN1 | |
| SCHEMBL3051061 | 0.82 | ALDH1A1 (0.74) | ALDH1A1RAB9AKMT2ANPC1MEN1 | |
| SCHEMBL3057932 | 0.81 | MAPT (0.73) | ALDH1A1RAB9AKMT2ANPC1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2200977-B1 | F1F0-ATPASE INHIBITORS AND RELATED METHODS | UNIV MICHIGAN (US) | 2016-11-09 | — | — | EP | disclosed |
| US-8324258-B2 | F1F0-ATPase inhibitors and related methods | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2012-12-04 | — | — | US | disclosed |
| US-20100222400-A1 | F1F0-ATPase Inhibitors and Related Methods | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2010-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100222400-A1 | F1F0-ATPase Inhibitors and Related Methods | ATP5F1A, ATP5F1B, ATP5F1D | ALDH1A1 2038/4885RAB9A 855/4885KMT2A 4015/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.